Ligand validation:2DYR

TGL: TRISTEAROYLGLYCEROL

TGL is a Ligand Of Interest in 2DYR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2DYR_TGL_B_521	15%	46%	0.235	0.797	0.67	1.41	-	11	5	0	100%	1
2DYR_TGL_N_1521	12%	45%	0.243	0.775	0.71	1.4	1	10	9	0	100%	1
2DYR_TGL_D_523	10%	47%	0.232	0.735	0.76	1.28	1	9	2	0	100%	1
2DYR_TGL_Q_1523	6%	46%	0.232	0.667	0.8	1.26	2	9	2	0	100%	1
2DYR_TGL_L_522	5%	29%	0.302	0.708	1.11	1.72	4	13	17	0	100%	1
2DYR_TGL_N_1522	3%	28%	0.316	0.626	1.15	1.7	4	13	10	0	100%	1
5B1A_TGL_B_301	58%	8%	0.119	0.898	1.71	2.82	8	21	2	0	100%	1
5ZCQ_TGL_A_608	51%	22%	0.146	0.899	1.36	1.87	5	11	1	0	100%	1
5ZCP_TGL_A_608	49%	17%	0.149	0.895	1.31	2.24	6	10	1	0	100%	1
5B3S_TGL_B_301	48%	36%	0.154	0.897	1.1	1.4	3	6	3	0	100%	1
6JUW_TGL_A_610	48%	36%	0.137	0.878	1.18	1.34	3	6	0	0	100%	1
7W3E_TGL_B_301	46%	30%	0.145	0.881	1.18	1.61	3	9	2	0	98%	0.9841

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.